ROR2 and melanoma: ROR2 is a component of the non-canonical WNT pathway [48], which has been implicated in the phenomenon of dynamic phenotype switching in which melanomas switch from a highly proliferative, non-invasive phenotype to a phenotype associated with invasion, increased motility and high metastatic potential [28, 31].